Winton Capital »

Vor Biopharma shares owned by Winton Capital

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $212k 12k 17.84

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Ge Vernova (GEV)
Booking Holdings (BKNG)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
CSX Corporation (CSX)
Solstice Advanced Matls Com Shs (SOLS)
Kroger (KR)
AES Corporation (AES)
Entegris (ENTG)
Electronic Arts (EA)
Hologic
Masimo Corporation (MASI)
Stifel Financial (SF)

View all positions for Winton Capital

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma